Best Hospitals for Multiple sclerosis treatment in Poland 2026

Stem-cell therapy for multiple sclerosis is not a standard medical treatment in Poland. It is legally available only as an experimental procedure or through clinical trials. All treatments must follow European Medicines Agency standards. Some private clinics utilize hospital exemptions for non-registered advanced therapies.

• Regulatory status: The Ministry of Health classifies neurological stem-cell use as strictly experimental.
• Access methods: Patients typically access therapy through registered clinical trials or specific hospital exemptions.
• Clinical oversight: Procedures must align with Advanced Therapy Medicinal Products (ATMP) regulations and European standards.
• Primary providers: Specialist centers in Warsaw and Krakow conduct research and Phase 2 trials.

Bookimed Expert Insight: While many seek stem-cell therapy, Poland's high-volume academic centers like the University Hospital in Krakow focus on established protocols. This facility manages 455,000 patients annually across 103 departments. Data suggests that patients often find more predictable outcomes by combining rehabilitative care at specialized resorts with standard neurology consultations at these large-scale teaching hospitals.

Patient Consensus: Patients note that while private access has shorter wait times of 3–6 months, the treatment requires intense preparation. Many highlight the necessity of 6-month isolation periods to manage infection risks after the procedure.

AHSCT for MS in Poland is a safe procedure when performed at specialized centers following strict eligibility protocols. Data from Polish institutions indicate a 0% transplant-related mortality rate in reported patient cohorts. Facilities utilize intensive pre-screening and modern protocols to maximize safety and efficacy during treatment.

• Survival rates: Polish medical centers report a 100% survival rate during the post-transplant observation period.
• Long-term efficacy: Studies show 82% of patients experienced no disability progression four years after treatment.
• Infection control: Clinical protocols using prophylactic antibiotics keep procedure-related infection rates under 10%.
• Patient selection: Safety is maintained through strict screening, including cardiac, lung, and brain MRI reviews.

Bookimed Expert Insight: Polish hematology centers prioritize safety by enforcing strict EDSS score limits. While some regions accept patients with advanced disability, major Polish centers often focus on earlier-stage aggressive MS. This selective approach, combined with the 455,000 annual patient capacity at institutions like University Hospital in Krakow, creates a high-volume environment with specialized expertise.

Patient Consensus: Patients note that while the chemotherapy phase causes intense fatigue for weeks, the long-term restoration of mobility is life-changing. Many emphasize the necessity of budgeting for a 6-month home recovery period to manage lingering infection risks.

The patient pathway for multiple sclerosis treatment in Poland typically spans 5 to 6 weeks total. This journey includes 3 to 5 days of diagnostic evaluation followed by 21 to 28 days of inpatient care. Most patients stay in specialized units for intensive protocols like hematopoietic stem cell transplantation (HSCT) or plasmapheresis.

• Initial assessment: Diagnostic tests including brain MRI and bloodwork take 3 to 5 days.
• Treatment phase: Active inpatient protocols usually require a 21 to 28 day hospital stay.
• Recovery monitoring: Patients spend approximately 14 days in isolation to manage infection risks.
• Post-discharge stay: Doctors recommend staying locally for 1 to 2 weeks for follow-up.

Bookimed Expert Insight: Data from major Polish centers like University Hospital in Krakow shows a preference for longer inpatient monitoring. While some international clinics discharge patients earlier, Polish protocols often require a full 25-day stay in sterile rooms. This cautious approach helps medical teams manage common side effects like fever or neutropenia immediately. High-volume centers with over 1,000 beds provide the necessary infrastructure for these extended stays and continuous specialist access.

Patient Consensus: Patients note that completing dental and heart checks before arriving prevents delays in the pathway. They emphasize budgeting for a 6-week trip to account for potential recovery extensions due to fatigue or minor infections.

Select Polish centres with JCIM (Centrum Monitorowania Jakosci) accreditation for national safety compliance. Seek facilities with JCI and ISO 9001 certifications for international quality benchmarks. Verify neurologists hold NIL (Naczelna Izba Lekarska) registration and specialized experience in procedures like plasmapheresis or Ocrevus administration.

• National oversight: CMJ accreditation ensures strict Polish protocols for infection control and patient rights.
• Quality standards: JCI and ISO 9001 certifications confirm professional management and global safety benchmarks.
• Specialized expertise: Seek doctors with specialized board certifications from the European Society for Quality.
• Facility capacity: Leading university hospitals manage over 450,000 patients yearly with 100+ specialized departments.

Bookimed Expert Insight: Quality markers in Poland often follow a high-volume model. University Hospital in Krakow manages 455,000 patients annually with over 1,000 doctors. This high patient volume typically correlates with more refined clinical protocols for complex neurological protocols. While private clinics offer comfort, these large academic centers provide more extensive diagnostic departments and emergency backup.

Patient Consensus: Patients suggest verifying if the hospital has EBMT affiliation for advanced treatments involving cell therapy. Many note that public hospitals with NFZ contracts often provide more rigorous oversight than smaller private setups.